Imexpharm

Imexpharm Net Debt per Share

The Net Debt per Share of Imexpharm (IMP.VN) as of Oct 26, 2026 is 1,381.60 VND. In the previous year, Net Debt per Share was 559.20 VND — a change of 147.07% (higher).

Net Debt per Share

1,381.60VND

YoY

147.07%

Last updated:

Net Debt per Share of Imexpharm is 2025 1,381.60 VND. Net Debt per Share of Imexpharm was 2024 559.20 VND. It decreases by 147.07% higher compared to the previous year.

The Imexpharm Net Debt per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Debt per Share
Date
Net Debt per Share
Jan 1, 2018
-1,264.33 VND
Jan 1, 2019
244.01 VND
Jan 1, 2020
850.13 VND
Jan 1, 2021
1,712.85 VND
Jan 1, 2022
616.72 VND
Jan 1, 2023
320.90 VND
Jan 1, 2024
559.20 VND
Jan 1, 2025
1,381.60 VND
The Imexpharm Net Debt per Share history
YEARNet Debt per ShareYoY
1,381.60VND+147.07%
559.20VND+74.26%
320.90VND-47.97%
616.72VND-63.99%
1,712.85VND+101.48%
850.13VND+248.40%
244.01VND-119.30%
-1,264.33VND-32.74%
-1,879.78VND+150.61%
-750.09VND-39.65%
-1,242.85VND+5.27%
-1,180.67VND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Imexpharm Stock analysis

What does Imexpharm do? Imexpharm Corp manufactures and trades pharmaceuticals, medicinal chemicals, and botanical products, including antiseptics, traditional medicine, medical equipment, cosmetics, and supplemental food and drinks. The company provides packaging and warehousing services specifically for pharmaceutical storage. It also cultivates medicinal herbs. Imexpharm Corp serves the pharmaceutical industry and healthcare sector through its manufacturing, import, export, and trade operations, targeting businesses requiring medicinal products and services. The company's revenue streams include the sale of manufactured pharmaceuticals, imported and exported goods, and services such as packaging and warehousing. Its customers are businesses in the healthcare sector, including distributors and retailers of pharmaceuticals, medical equipment, and related products. The firm's operations span manufacturing, import, export, and trade, with additional services supporting the pharmaceutical supply chain. Imexpharm Corp's product portfolio covers a wide range of medicinal and health-related items, from antiseptics to supplemental food and drinks. The company's involvement in medicinal herb cultivation supports its production of traditional medicine and herbal-based products. This vertical integration enhances its ability to supply comprehensive solutions to healthcare businesses. Imexpharm is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Imexpharm stock

Net Debt per Share of Imexpharm is 1,381.60 VND in 2025.

Net Debt per Share of Imexpharm changed from 559.20 VND to 1,381.60 VND, representing a 147.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Net Debt per Share Imexpharm since 2006 – with annual values, charts, and detailed analysis.

Net debt per share divides net debt by shares outstanding, showing the debt burden attributable to each share after accounting for cash reserves.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Other — Imexpharm

All Key Metrics — Imexpharm